The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > September 9, 2025
Daily News
September 9, 2025
- JPMA Quality Committee Launches Task Force on DX in Commercial Production
September 9, 2025
- Lilly Japan Ramps Up Seishin Plant with New Building and Packaging Line
September 9, 2025
- Janssen Files TAR-200 in Japan for High-Risk Bladder Cancer
September 9, 2025
- Amicus CEO Confident on US$1 Billion Sales Target as Japan Pompe Launch Gets Underway
September 9, 2025
- GSK Recalls 7 Lots of Omjjara in Japan over Quality Issue
September 9, 2025
- Takeda Nabs Label Expansion for VWD Drug Vonvendi in US
September 9, 2025
- Japan Panel Approves 5 COVID Vaccines for NIP Use from October
September 9, 2025
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…